Aprindine

This classification denotes an antiarrhythmic agent with the molecular formula C22H30N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 5Y48085P9Q, chemically known as 1,3-propanediamine, n-(2, 3-dihydro-1h-inden-2-yl)-n,n-diethyl-n-phenyl-, monohydrochloride but more generally known as aprindine, which bears US NIH Compound Identifier 2218. Aprindine most often comes in base and hydrochloride forms. European Medicines Agency schedules Aprindine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05542MIG. The term APRINDINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules aprindine in its Anatomical Therapeutic Chemical (ATC) Classification. APRINDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule aprindine under HS 29215990 and SITC 51455. As of Q4 2014, APRINDINE remains US FDA's Preferred Term for this commodity. Aprindine bears US NLM identifiers UMLS ID C0003639 and NCI Concept Code C77975. SMILES: N(C1CC2C(C1)CCCC2)(CCCN(CC)CC)C1CCCCC1.